Zelira Therapeutics Limited

Zelira Therapeutics Limitedverified

ZLD.AX

Price:

$0.34

Market Cap:

$4.05M

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of various medical conditions in Australia. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. The company also provides OTC products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as ITURA, an advanced relief cream formula that targets multi-symptoms, such as numbness and tingling, muscle cramps, insensitivities, and pain associated with Peripheral Artery Disease and di...[Read more]

Industry

Biotechnology

IPO Date

2003-07-25

Stock Exchange

ASX

Ticker

ZLD.AX

The ROE as of December 2025 (TTM) for Zelira Therapeutics Limited (ZLD.AX) is 56.41%

According to Zelira Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is 56.41%. This represents a change of -85.61% compared to the average of 392.08% of the last 4 quarters.

Zelira Therapeutics Limited (ZLD.AX) Historical ROE (quarterly & annually)

How has ZLD.AX ROE performed in the past?

The mean historical ROE of Zelira Therapeutics Limited over the last ten years is 101.92%. The current 56.41% ROE has changed -44.65% with respect to the historical average. Over the past ten years (40 quarters), ZLD.AX's ROE was at its highest in in the December 2023 quarter at 1.46%. The ROE was at its lowest in in the June 2009 quarter at -408.98%.

Quarterly (TTM)
Annual

Average

101.92%

Median

-21.45%

Minimum

-114.80%

Maximum

809.96%

Zelira Therapeutics Limited (ZLD.AX) ROE by Quarter and Year

Discovering the peaks and valleys of Zelira Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 312.41%

Maximum Annual ROE = 809.96%

Minimum Annual Increase = -4721.97%

Minimum Annual ROE = -114.80%

Quarterly (TTM)
Annual
YearROEChange
202581.33%-89.96%
2024809.96%-4721.97%
2023-17.52%-48.36%
2022-33.93%50.15%
2021-22.60%11.29%
2020-20.31%-82.31%
2019-114.80%312.41%
2018-27.84%-64.30%
2017-77.98%-117.61%
2016442.88%-496.16%

Zelira Therapeutics Limited (ZLD.AX) Average ROE

How has ZLD.AX ROE performed in the past?

The current ROE of Zelira Therapeutics Limited (ZLD.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

291.26%

5-year avg

163.45%

10-year avg

101.92%

Zelira Therapeutics Limited (ZLD.AX) ROE vs. Peers

How is ZLD.AX’s ROE compared to its peers?

Zelira Therapeutics Limited’s ROE is less than AdAlta Limited (1.80%), greater than Anatara Lifesciences Ltd (-164.64%), greater than TALi Digital Limited (-31.45%), greater than Acrux Limited (-268.28%), greater than Biotron Limited (-63.03%), greater than Careteq Limited (-5.86%), greater than Elixinol Wellness Limited (-24.24%), less than Imagion Biosystems Limited (71.61%), less than Osteopore Limited (5.55%), greater than Oakridge International Limited (-14.26%),

Build a custom stock screener for Zelira Therapeutics Limited (ZLD.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zelira Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zelira Therapeutics Limited (ZLD.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zelira Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Zelira Therapeutics Limited's ROE?

How is the ROE calculated for Zelira Therapeutics Limited (ZLD.AX)?

What is the highest ROE for Zelira Therapeutics Limited (ZLD.AX)?

What is the 3-year average ROE for Zelira Therapeutics Limited (ZLD.AX)?

What is the 5-year average ROE for Zelira Therapeutics Limited (ZLD.AX)?

How does the current ROE for Zelira Therapeutics Limited (ZLD.AX) compare to its historical average?